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Abstract
To achieve transition from lab scale enzyme studies to industrial applications, under-
standing of enzyme kinetics plays a critical role. The widely applied Michaelis Menten
equation of the single substrate kinetics, sequential and double replacement mechanism
of bisubstrate reaction and the relevant kinetics, inhibition and activation of enzyme are
all integral parts of this discussion. In this chapter, we have discussed different types of
inhibition and kinetic modelling. Systematic approach to generate data and its interpre-
tation as well as designing of inhibitors is also explained.
Keywords: enzyme catalysis, mechanism, activation, deactivation, assay methods,
inhibition, kinetic modelling, microwave irradiation
1. Introduction
The chapter gives brief introduction of enzyme, its classification and kinetics. It also discusses
about the different types of inhibitions and activations involved in the enzymatic reactions.
The classification of different types of enzyme inhibitors and activators and their mechanism of
action will also be explained with appropriate examples. It will also give gist of different
methods to identify inhibition or activation of specified reaction by given molecule. Different
types of kinetic models used for the enzyme inhibition and activation will be systematically
discussed with case studies. The applications of bioinformatics and computational modelling
for in-vitro designing of the modulators and the study of transition states of enzyme-inhibitor
complex will also be brought into light. The new developments and future challenges are
summarized in this chapter. Enzyme catalysis, classification and effect of physiological condi-
tions are also discussed.
Continuous rigorous efforts have been put into the understanding of enzymatic kinetics in
order to use them for reactor design and industrial applications. The systematic study of the
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reactivity of enzymes under different controlled external conditions reveals the reaction mech-
anism, activation and deactivation of enzymes and their reactivity towards a given set of
substrates [1–4]. The crystallographic data supporting three-dimensional structural properties
and mechanism in combination with the kinetic data serve as a powerful tool to understand
working principles of enzyme in cellular fluids and thereby provide an opportunity to design
the therapeutic molecules [1, 2]. International Commission on Enzymes was instituted by the
joint efforts of International Union of Pure and Applied Chemistry (IUPAC) and International
Union of Biochemistry (IUB) which have classified and assigned an EC number to each
enzyme. The respective four-digit enzyme commission (EC) number associated with the
enzyme signifies the details about the reactions catalysed by the enzyme. The readers can refer
the biochemistry literature present in the books written by Stryer, Voet and Voet [3], Nelson
and Cox [4] and the official website of the enzyme classification [5, 6]. Enzymes as the
biological catalyst are mainly classified in six classes, namely, oxidoreductase, ligase, lyase,
transferases, isomerase and hydrolases [3–5, 7, 8]. More importantly, enzymes do not alter the
equilibrium constants of chemical reaction as they also have the ability to catalyse backward
and forward reactions. Hence, they only affect the rate at which the equilibrium is established.
However, as almost all the biological systems in human body work at the steady state, the net
effect of enzyme to convert the substrate into the product occurs rapidly as the products are
removed instantaneously [4, 8, 9]. Various factors and physiological conditions affect the
activity and efficiency of enzymes to the various extents. Therefore, it is essential to understand
their effects on the enzymes [10, 11].
1.1. Effect of temperature
The fluctuations in temperature can affect the activity of enzymes in either way, i.e. they may
cause activation or deactivation, depending on the nature of enzymes and properties of the
solution. In most of the catalytic reactions, the average kinetic energy and velocity of molecules
rise with increase in temperature, which results in higher probability of effective collisions and
the cumulative changes lead to increase the rate of reaction with temperature [12–14]. Below
the denaturation temperature, on an average, rate increases with per 10C increase in temper-
ature. Ratio by which rate changes for 10C rise is known Q10 (approximately from 1.7 to 2.5).
Generally, as the enzymes are evolved to work with optimum efficiency at physiological
conditions of the source microorganism, the same conditions are observed to be the optimal
conditions for most of the enzymes at which the rate of reaction is maximum. [18] concluded
that in the case of macro-heterogeneous systems such as lipase, the rate of reaction of enzymes
is partly regulated by diffusion and partly by temperature. Inactivation by heat expends on
stability of the enzyme up to certain temperature range at different experimental conditions.
However, purified enzymes have higher probability of deactivation than crude enzymes. This
is because the liability is often subsidized by the protective protein and their colloids associ-
ated with the enzymes of interest. Therefore, the critical temperature and temperature coeffi-
cient depend upon properties and composition of the enzyme preparation along with the
properties of enzyme itself. The critical temperature is at which the activity of its enzyme is
destroyed to half of the reactions. If the enzymes are used for the reaction at higher
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temperature than optimum, it catalyses the reaction and will get deactivated over the period of
time. If the temperature is lowered to optimum, reaction will be completed earlier. When the
optimum temperature is maintained slightly above the critical temperature of inactivation,
reaction will reach to the completion at a faster rate. Practically, optimum temperature gives
rough idea of heat stability of enzymes and there are no other significant data available at this
temperature. Hence, it does not serve as a definite character even for the given enzyme system.
In some cases, increase in catalase activity in a yeast cell suspension occurs by 49 times after
heating for an hour. This is attributed to the destruction of an inhibitory substance at higher
temperatures. Similar properties are observed for the blood catalase due to hemolysis as
corpuscular enzyme differs from the intra-corpuscular enzyme in its properties [15].
1.2. Action of radiations on enzyme
The exposure of enzyme solution to the various radiations generally leads to an irreversible
destruction, occasionally an activation of the enzymes [16]. The rate of destruction is practi-
cally independent of temperature during the treatment of enzyme preparation with radiations.
Perhaps, it is affected by pH and chemical conditions like presence of substrate, optical
sensitizers and oxygen [17, 18]. While enzymes are very stable to heat inactivation near their
optimal pH, the reverse is often the case with regard to ultraviolet (UV) radiations. Generally,
diluted solutions are more affected by the UV radiations than the concentrated ones due to
absence of protective colloids and ions. The deactivating effect of X- and γ-rays may be due to
the electrons ejected by them which lead to the inactivation of enzymes [19]. In case of
radioactive sources, the amount of deactivation can be calculated. If Q is the amount of
enzyme present, then
I
Q
dQ
dW
¼ c (1)
whereW is an average activity of radioactive source and c is a constant multiplied by time over
which it acts.
1.3. Effect of microwave radiations
Since last five decades, microwave irradiations have been established as an efficient source of
heat energy for chemical reactions, wherein rate of reactions has been enhanced by a multiple
fold than conventional heating and has led to the reduction in overall reaction time drastically
with high selectivity. The electromagnetic components of microwave irradiation lead to the
vibration of bonds to chemical reactants and catalysts resulting into the lowering of activation
energy and increase in collision frequency [20, 21]. Microwave irradiation triggers the effect
that cannot be created with the help of thermal heating. Especially, in case of polar solvent
molecules, it acts as a bridge between two molecules through absorption energy [22–24]. The
enzyme hydration layer can be used for the improvement of the process or modification of the
selectivity as it interacts with the microwave radiations [25–27]. Hence, the microwave irradi-
ation affects synergistically to the enzymes.
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1.4. Effect of pH
The optimal pH of the enzyme is generally the same as that of fluid at which enzyme functions
in vivo. Enzyme activity profile is bell shaped curve signifying that before and after the optimal
pH, the activity of the enzyme decreases drastically. The presence of charged amino acids in
enzyme structure, chemical nature of substrate and enzyme-substrate complexes is the reason
for the pH dependence of enzyme [28]. Hence, pH causes dissociation or undissociation of the
charged amino acids that affect catalysis. Ionization of these groups depends upon pKa values.
The pH and nature determine the pKa value of the medium. The change in pH alters interac-
tion of the substrate with an active site and rate of breakdown of enzyme-substrate complex
into product [29–31]. The effect of pH on the biocatalysed reaction can be represented with the
change in Vmax and Km which is summarized in Scheme 2.1 and Expression 2.1.
E ES
↑↓KE2 ↑↓KES2
EH þ S ⇄
k1
k1
ESH !
k2
EH þ P
↑↓KE1 ↑↓KES1
EH2þ ESH2þ
(2)
Scheme 2.1: Mathematical equations modelling pH effects on enzyme catalysed reactions.
v ¼
Vmapp½S
Kmapp þ ½S
(3)
Vmapp ¼
Vm
1þ ½HþKes1 þ
Kes2
½Hþ
(4)
Kmapp ¼
Kmð1þ
½Hþ
Ke1
þ Ke2½HþÞ
1þ ½HþKes1 þ
Kes2
½Hþ
(5)
Expression 2.1: Kinetic expression for the effect of pH on enzyme catalysed reactions.
1.5. Effect of immobilization
With the purpose of reusability, enzymes are immobilized on porous and non-porous solid
medium using various methods. This immobilization along with the stabilization of the
enzyme brings the extrinsic and intrinsic diffusional limitations and increased probability of
substrate or product inhibition. The kinetic constants (e.g. Km, Vmax) of immobilized enzymes
may be altered by the process of immobilization, intrinsic specificity of enzymes, properties of
the solution and molecular diffusion within the local environment [32–34]. The relationship
between these intrinsic and apparent parameters is shown below.
Damkohler number ðDaÞ ¼ Maximum rate of reaction=maximum rate of diffusion ¼
V
0
max
KL½Sb
(6)
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If Da >> 1, diffusion rate is limiting the observed rate.
If Da << 1, reaction rate is limiting the observed rate.
The Michealis Menten equation for the immobilized enzyme is represented in equation (7).
vs ¼ η
V
0
max½Sb
Km þ ½Sb
(7)
Expression 2.2: Modified Michealis Menten equation for immobilized enzymes.
The substances are partitioned in the two environments, internal solution and surrounding of
the immobilized enzyme. Substrate molecule (Sb) diffuses to the micro-environment of cata-
lytic centre from the macro-environment to convert into product (P) [35].
2. Study of enzyme mechanism and kinetics
2.1. Study of enzyme mechanism
To study the mechanism of enzyme catalysis, one should be able to estimate the inferences of
the experimentally observed effects with respect to the change in molecular events. The basic
mechanism can be predicted and validated for the enzymatic reaction under investigation by
analysing the data available from a number of techniques. Combination of the basic physico-
chemical properties with steric structure and quantum mechanical calculations gives solid
foundation for the prediction of mechanism [36]. The kinetic data and graphical representation
validate the data and play a crucial role in establishing the mechanism of the enzyme. Addi-
tionally, the study of enzyme inhibition not only unveils the mode of action of enzyme but also
opens up other crucial information which is boon to the other fields of science. Some of the
methods that are used for the prediction of the mechanism of the enzymatic catalysis are
isotope exchange, irreversible inhibition, pH dependence, fluorescence labelled substrates,
etc. [37].
2.2. Study of enzyme kinetics
To upscale the laboratory level research to an industrial scale with improved productivity and
reduction in cost of the process, it is very necessary to study the kinetic models of the desired
biocatalytic reactions, which facilitate process designing and intensification [38, 39]. The
understanding of enzyme kinetics is also essential to design modulator that can help in
designing various drugs. Transient-state kinetics, steady-state kinetics and rapid-equilibrium
kinetics are the three major classes of kinetic studies [40–42]. Transient-state kinetics is applied
to the very fast reactions of which mechanisms are dependent on the enzyme structure [43, 44].
The steady state of enzyme kinetics is derived with the hypothesis that each enzymatic step is
in steady state and remains in steady state, even though the outer environment continuously
changes in a given catalytic system [36, 45]. For rapid equilibrium kinetics, the reaction
components of the step, preceding to the rate determining step, are in equilibrium with various
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enzyme forms like the enzyme, enzyme-substrate complex and substrate [46–48]. The initial
velocity of the enzyme catalysed reaction gets affected by the modifiers [49]. The addition of
single type of modifier changes the kinetics and yields two rate constants, whereas addition of
two types of modifiers in two different reactions; five independent equilibrium conditions and
three routes for synthesizing products are observed [50]. The chemical equilibrium is signifi-
cantly affected by the external conditions such as drugs, activators, metals, toxins and pH,
some of which were discussed earlier in Section 2. However, the enzyme kinetics can differ
marginally in a cellular environment because of the dynamic nature of system [41].
2.2.1. Single substrate kinetics
In 1902, Brown found that at high concentration of sucrose, reaction follows zero-order reac-
tion. Therefore, he proposed that the reaction is composed of two elementary steps. (1) Pre-
steady-state: the formation of ES complex (2) At steady state: formation of product. This
initiated the study of enzyme kinetics and derivation of the relevant rate expression (6 and 7).
The next significant efforts were put forth by Michaelis and Menten in 1913 which were further
improved by Briggs and Haldane [3, 7]. The reaction rate is directly proportional to [E] if
excess of free substrate concentration is present. At low substrate concentration, reaction
follows first-order kinetics. Enzyme substrate interaction obeys the mass action law. For given
[E], reaction velocity increases initially with increasing substrate concentration up to certain
maxima and further addition does not change the velocity anymore. Plotting and shaping of
rectangular hyperbola characterize the shape of non-allosteric enzymes [8, 33]. The progress
curve for the simple enzyme for catalysed reaction is represented in Figure 1.
Figure 1. Progress curve for simple enzyme for catalysed reaction [7].
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Unfortunately, steady-state kinetics measures are incapable of revealing the number of inter-
mediates. It is referred as ‘black box’. Perhaps, it provides phenomenal description of enzy-
matic behaviours. The nature of intermediate remains indeterminate. Hence, even though
steady-state kinetics is not helpful for predicting the mechanism, it is useful to eliminate the
proposed mechanisms [8, 51]. This developed expression relates initial rate of reaction with the
substrate concentration and rate constants. The representation of reaction is as follows:
Sþ E⇄
k1
k1
ES!
k2
Eþ P (8)
In the given rate expression, the first step is reversible, whereas second step became irrevers-
ible. The second step is not reversible as the sufficient amount of energy is not available to
cross the barrier as the energy liberated during the reaction. To derive the rate expression for
the desired single substrate enzymatic reaction, following assumptions are made [3, 4].
1. Concentration of substrate ([S]) is greater than the concentration of enzyme ([E]): concen-
tration of substrate is not so large that all enzyme become enzyme-substrate (ES) complex
form. But, it must be sufficiently large so that the concentration of substrate does not
rapidly become so small that concentration of substrate becomes larger than the concen-
tration of enzyme. Under these conditions, concentration of ES complex rapidly becomes
constant, so that the rate of formation of ES complex is equal to the rate of breakdown of
ES complex wherein steady-state kinetics can be applied.
2. Only initial velocities are measured so that the concentration of substrate is not depleted
during the measurement (velocity measured before more than ~10% of conversion). Initial
velocity measured below ~10% minimizes interference by parameters like reversible
nature of reactions, inhibition of the enzymes by its product and progressive inactivation
of the enzymes.
3. Concentration of the ES complex is static throughout the process which infer that:
a. Sufficient time has passed, which is needed to build the concentration of the ES
complex after mixing of E and S.
b. Adequate time has been given to the reaction for the rate of formation of ES complex
resulting into the depletion of substrate.
c. If it is k2 >> k1, ES complex breakdown occurs as rapidly as it is produced to form
product and thus steady state can never be achieved. When k2 << k1, the concentra-
tion of ES can build up inside the system and then,
Rate of formation of ES complex ¼
d½ES
dt
¼ k1½E½S (9)
¼ k1ð½ET  ½ESÞ½S (10)
Rate of breakdown of ES complex ¼
d½ES
dt
¼ k1½ES þ k2½ES (11)
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Under steady state conditions,
Rate of formation of ES complex = rate of breakdown of ES complex
k1ð½ET   ½ESÞ½S ¼ ðk1 þ k2Þ½ES (12)
Rearranging the Eq. (12)
ð½ET  ½ESÞ½S
½ES
¼
k1 þ k2
k1
¼ Km (13)
Wherein, Km = Michealis Menten constant which is a ratio of rate constant and not an equilib-
rium constant.
½S½ET   ½S½ES ¼ Km½ES (14)
½S½ET ¼ ðKm þ ½SÞ½ES (15)
½S ¼
½ES
½ET
ðKm þ ½SÞ (16)
At any point of time, it is very difficult to measure the concentration of enzyme-substrate
complex in the system. Hence, Eq. (16) is not useful experimentally to deduce any quantitative
results. On the contrary, various experimental methods can be used for quantify the velocity (v)
and maximum velocity (Vmax). Therefore, Vmax is the limiting value, if ½S ! ∞. In this case, all
enzymes are bound to the substrate and [E] = 0, [ET] = [ES]. Thus,
v ¼ k2½ES (17)
Vmax ¼ k2½ET (18)
k2 ¼
v
½ES
(19)
k2 ¼
Vmax
½ET
(20)
v
Vmax
¼
½ES
½ET
(21)
So, after putting these substitutes, Eq. (16) becomes,
½S ¼
v
Vmax
ðKm þ ½SÞ (22)
This expression is known as Michealis Menten equation for the prediction of enzyme kinetics.
This is the most widely accepted and applied enzyme kinetics to the various systems in vitro
and in vivo.
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Deductions derived from the Michealis Menten expression:
i. Michealis Menten constant (Km) does not change for desired enzyme and is independent
of the concentration of substrate and enzyme.
ii. Maximum velocity (Vmax) depends on concentration of enzyme and at saturating concen-
tration it is independent of substrate concentration.
iii. Both Km and Vmax may be affected by temperature, pH, immobilization and other phys-
ical constraints.
iv. A graph of velocity (v) versus concentration of substrate [S] fits hyperbolic rectangular
function.
v. If enzyme can catalyse more than one reaction, then Km values can be used to measure the
relative affinity towards particular substrate. If Km increases, affinity of substrate towards
enzyme decreases. In metabolic pathway studies, rate limiting step from the sequential
pathway is determined with the values of Km for that enzyme for different substrate.
vi. When k1 >> k2, concentration of ES complex is implied that it reaches to equilibrium with
concentration of enzyme and substrate and ES is dissociated to yield the product. Under
these conditions, the dissociation constant of enzyme substrate complex (Ks) is,
KS ¼
½E½S
½ES
¼
k1
k1
(23)
Km ¼
k1 þ k2
k1
(24)
Km ¼
k1
k1
¼ KS k1≫k2 (25)
vii. When k2 >> k1, the rate of dissociation is low so that the rate of product formation is high,
reaction sequence becomes irreversible at both steps.
Eþ S!
k1
ES!
k2
Eþ P (26)
As overall rate of reaction is determined by the concentration of ES complex,
• At low substrate concentration, formation of ES complex follows second-order reac-
tion. The rate of reaction is proportional to the concentration of enzyme and sub-
strate.
• At high substrate concentration, [ES] complex remains constant and reaction rate is
proportional to the [ES] complex. The reaction follows the first-order reaction rate.
viii. The turnover number is defined as the rate at which an enzyme can accomplish its
catalytic activity per unit time or it can also be defined as a frequency at which the ES
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complex leads to the formation of product. When [S] >> Km, the turnover number for the
enzyme is calculated. It can be determined under saturation conditions as,
dP
dt
¼ Vmax ¼ k2½ES ¼ k2½ET (27)
If [ET] increases x-times, while concentration of substrate is established at the saturating
levels as compared to the total concentration of enzyme, then Vmax increases x-times. The
rate of reaction is proportional to the concentration of total enzyme concentration. The
reaction tends to become first order.
In saturation condition, the rate of reaction is maximum. The rate constant k2 is denoted
as kcat at saturation levels and gives the value of turnover number. It ranges from 1 to 10
4
per second. Sometimes, it reaches to 105. Upper limit to the value of kcat/Km cannot be
greater than k2 i.e. decomposition of ES complex to E and P. The most efficient catalyst has
values of kcat/km near the controlled diffusion limits of 10
8
–109 m1 s1. These enzymes
catalyse reaction almost every time they colloid with substrate and achieve virtual cata-
lytic perfection.
kcat ¼
Vmax
½ET
(28)
The ability of enzyme to produce a given amount of product to use in given time is
changes proportionally with turnover number and total amount of enzyme present in
cell. However, turn over number is measured for purified enzymes. Hence, the enzyme
activity is measured as a specific activity (μmol of substrate converted per minute per mg
of enzyme to form product). That is also denoted as Katal (kat). It is defined as concen-
tration of enzyme that transforms 1 mol of substrate into product per second. As for most
of the clinical disorders, activity is measured in biological fluids. It is redefined as 1 μmol
of substrate to product per minute at optimal conditions (IU).
ix. When concentration of substrate is far less that the value of Km, the product formation
rate rises linearly with rise in substrate concentration and reaction becomes first order
with reference to the concentration of substrate.
At low substrate concentrations, reaction rate is proportional to the total enzyme concen-
tration. Reaction velocity at low concentration of substrate can be represented as,
v ¼ k
0
½E½S (29)
k
0
¼
kcat
Km
(30)
Therefore, the rate equation must specify a second-order dependence on the concentra-
tion of substrate and total enzyme. When concentration of substrate is small there is first
order dependence in concentration of total enzyme alone. When concentration of sub-
strate is large, rate constant is kcat for first order and kcat/Km for second order in which
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Km is the value of the concentration of substrate. When v ¼
1
2Vmax, kcat/Km measures total
activity of the enzyme, which includes the ability of enzyme to bind with a particular
substrate.
x. When Km = [S], results in the velocity that is Vmax/2,
Vmax
2
¼
Vmax½S
Km þ ½S
(31)
Km þ ½S ¼ 2½S (32)
Initial velocity increases with increase in Vmax at constant concentration of the substrate
and Km and Initial velocity decreases with increase in Km at constant concentration of the
substrate and Vmax.
- Limitation of Michealis Menten relation:
It is very tedious to quantify the velocity of the enzyme which can catalyse the multiple
reactions. In other cases, the enzyme may be inactivated by its substrate or impurities in it.
The enzyme that consists of several components and velocity-substrate relationship depend
upon their ratios (e.g. urease). In these cases, the use of Michealis Menten equation cannot be
accurately predicted.
- Representation of Michealis Menten Data:
For enzyme catalysis the data mostly fit into a rectangular hyperbola wherein the initial
velocity of reaction is plotted against the concentration of substrate in the system [52, 53]. It
can be represented as follows (Figure 2):
Figure 2. Initial velocity of reaction versus the concentration of substrate [4].
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In the direct diagram, Vmax and Km are calculated by extrapolating the graph. As from the
given data points, there are numerous ways to represent the data. Secondly, as the experiment
is conducted at the saturation level, it is often that velocity is overlooked and therefore Km.
Also, the inhibitory effect of the excessive substrate or the limited solubility of the substrate
causes the misinterpretation of the values of kinetic parameters. Practical prediction of this
error prone data becomes more tedious as it becomes very difficult to predict and evaluate the
experimental error from data. Hence, the need of accurate prediction of the data resulted into
development of various types of reciprocal and logarithmic plots derived on the basis of
Michealis Menten equation. Because straight lines are easier to evaluate, the efforts have been
taken to interpret that hyperbolic data in the form of a straight line by various ways like
Lineweaver Burk plot, Eadie Hofstee plot, Hanes plot, Dixon plot, etc. [47, 53].
• Lineweaver Burk plot (Double reciprocal plot)
It is based on the reciprocal of the Michealis Menten Equation and represented as,
1
v
¼
1
Vmax
þ
Km
Vmax
1
½S
(33)
The plot is developed by plotting the inverse of velocity of reaction against the inverse of
concentration of substrate with abscissa at 1/Km. This method is the most frequently used
method for the prediction of kinetic parameters. The major disadvantage is the irregular
distribution of data. The reciprocal action causes distortion of equally distributed substrate
concentrations either in the compressed form towards the co-ordinates or over-extended in the
other direction. To overcome the limitation, if the analysis is carried out at small range for
uniform dispersal of data, the results do not cover the range of study at satisfactory levels. The
tangible advantage of the linear graph is that the variables (v and [S]) are displayed on the
separate co-ordinators from each other. The external disturbances and change in mechanism
pattern cause the deviations from straight lines nature of the plot. This plot serves as primary
step to distinguish the inhibition in the system as well as it is useful to understand the
mechanism followed by the reactions [7, 8, 54].
• Eddie-Hofstee plot
Eddie-Hofstee plot is more equally placed in comparison with Lineweaver Burk plot. The
equation can be obtained as,
vð
km þ ½S
½S
Þ ¼ Vmax (34)
v
km
½S
 
þ v ¼ Vmax (35)
v ¼ Vmax  Km
v
½S
 
(36)
Plotting v against v/[S] gives Vmax from the ordinate intercept and –Km from the slope. This
method of linearization is not only associated with distortion of error limits at higher concen-
trations of substrates but also there is no separation of variables from each other [3, 55].
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• Hanes plot
The expression is derived by simple multiplication of the concentration of the substrate with
the reciprocal Michaelis-Menten equation. It is represented as,
½S
v
¼
Km
Vmax
þ
½S
Vmax
(37)
Plotting of [S]/v against [S] gives Km/Vmax (ordinate intercept) and 1/Vmax (slope). The error
limits are only slightly deflected at low substrate concentrations when simple linear regres-
sions can be applied. However, substrate concentrations variable is represented on both the co-
ordinates [7, 33].
• Eisenthal and Cornish-Bowden plot
Eisenthal and Cornish-Bowden have derived over a period of time in various forms. The final
equation of this type of direct linearization is represented as,
1
Km
¼
Vmax
Kmv

1
½S
(38)
By entering 1/v against 1/[S], 1/Km is quantified from the intercept and Vmax/Km from the slope
of the graph. The reciprocal transformation of the equation leads to the distortion of scale. The
deviation of the graph from the ideal behaviour is difficult to trace as it is overlapped by the
distortion error and gives the false values of kinetic constants [52, 56, 57].
• Dixon plot
In a Dixon analysis, two types of graphs are plotted to evaluate the type of inhibition that is
caused by the addition of the inhibitor in the reaction system. In 1953, the first Dixon plot of 1/v
versus concentration of inhibitor at static substrate level was studied. Based on the nature of
lines, this plot can be used to differentiate between the partial and complete inhibition
(Table 1).
In some cases, the plots create confusion in the prediction of non-competitive and competitive
inhibition. This led to the development of second Dixon plot ([S]ν1 is plotted versus [I])
(1972), which requires change in the turnover rate with respect to the inhibitor concentration
at a static saturating concentration of the substrate. In this case, the enzyme activity follows
hyperbolic decrease reaching to zero at complete inhibition. In case of the competitive inhibi-
tion, the lines plotted remain parallel to each other while in case of uncompetitive inhibition,
the Dixon plot showed the presence of intersecting lines [33, 55].
Type of inhibition Nature of Dixon plot I
Competitive inhibition Intersect with each other at I = Ki
Non-competitive inhibition Intersect on abscissa at I =Ki
Uncompetitive inhibition Remain parallel with each other
Table 1. Analysis of Dixon plots.
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There are some generalized methods that are used for determining various rate and inhibition
constants along with the prediction of mechanism that is followed by the reaction under
particular set of conditions.
2.2.2. Kinetics of two substrate reaction
The study of enzyme kinetics was initiated with the single substrate molecule which can be
further applied to study the bisubstrate reactions which constitute 60% of biochemical
bisubstrate reactions in nature [8].Two substrate reactions are more complex than single sub-
strate reactions. For example, most of dehydrogenase and aminotransferase follow bisubstrate
enzyme kinetics. The Cleland notation is used for the representation of higher order enzymatic
reactions. According to which, the substrates are assigned with A, B, C and D letters based on
the sequence of binding to the enzyme, products are assigned by letters P, Q, R and S on the
basis of release sequence. Enzyme is designated with letter E, and sometimes with F, which is a
slightly modified form of a stable enzyme observed in double-displacement reaction [58–60].
Hence forward, this notation is used for the representation of bisubstrate reaction. To study
reaction kinetics by applying Michaelis Menten kinetic to bisubstrate enzyme reactions, con-
centration of one of the substrates (B) is kept constant, whereas another one (A) is varied and
vice versa. As concentration of substrate B is kept arbitrarily constant, the obtained values of the
kinetic parameters for concentration of substrate A can be erroneous. On the other hand,
varying the concentration of both the parameters at a single point of time intricates large
complexity in data acquisition and analysis. Bisubstrate reactions can be broadly classified into
two groups, namely, sequential and double-displacement reactions. In sequential reaction
mechanism, both substrates bind to the enzyme which leads to the development of transition
state complex followed by the product. The binding of substrate decides further classification
of sequential reaction mechanism. When binding of one substrate A becomes obligatory prior
to other substrate B, then the reaction follows ordered sequential mechanism (Figure 3). On the
other hand, the sequence of binding of the substrates to the enzyme has very less importance,
the reaction undergoes random sequential reaction mechanism (Figure 4) [8, 33, 61].
These types of sequential mechanisms are further bifurcated into different sub-groups based
on the location rate limiting step. In case of a rapid equilibrium mechanism, the rate-limiting
step is chemistry of the reaction; on the other hand, step except chemistry of reaction controls
the rate of reaction for a steady-state ordered mechanism. In Theorell-Chance mechanism,
every step is fast except the release of the second product, Q, in a reaction pathway. For
steady-state random mechanism, the substrate binds with the enzyme in any order [55, 62].
Figure 3. Ordered sequential mechanism.
Enzyme Inhibitors and Activators86
As the name suggests, a double-displacement mechanism occurs when a catalytic process can
proceed with binding of one of the two substrates to the enzyme (Figure 5). On completion of
first catalytic event, first product (P) leaves from the active site leaving some of its portion
inside the active site. After the release of first product, some chemical group of substrate A left
behind in the catalytic site of the enzyme creating new form of stable enzyme (F). After binding
of second substrate, the catalysis proceeds further to produce product Q with the regeneration
of an original enzyme E. The plot of initial velocity and substrate concentration does not
signify any noticeable change in different types of mechanisms by visual inspection and hence,
not helpful in assigning any proper rate equation. However, the double-reciprocal plot, i.e. 1/v0
versus 1/[A] at the different concentrations of B, significantly distinct between a sequential or
ping-pong mechanism [13, 63, 64].
In case of sequential mechanism (ternary complex mechanism) of reaction, the lines on the
double reciprocal plot intersect with each other on the left of the x-axis (Figure 6), while that of
the double-displacement mechanism (ping-pong mechanism), the double reciprocal plot is
represented by the parallel lines (Figure 7) [58, 65, 66].
Thus, the double reciprocal plot gives clear indication of mechanism of reaction with some
exception [67]. The different rate equations and plot information are presented in Table 2.
The rapid-equilibrium random, steady-state ordered and Theorell-Chance mechanisms are
represented with the same rate expression and the primary plot or the double reciprocal plot
cannot differentiate between these mechanisms from each other. They only differ at the loca-
tion of rate limiting step and can be differentiated on the basis of kinetics studies such as dead-
end inhibition studies, isotope effects and pre-steady-state kinetics [55, 59, 68]. The bisubstrate
Figure 4. Random sequential mechanism.
Figure 5. Double-displacement reaction mechanism.
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Figure 7. Double reciprocal plot for double-displacement mechanism (at different levels of B).
Mechanism Rate equation Double reciprocal plots
Rapid equilibrium random sequential mechanism v ¼ VABðKiaþKbAþKaBþABÞ
Intersecting lines
Steady state ordered sequential mechanism v ¼ VABðKiaKbþKbAþKaBþABÞ
Intersecting lines
Theorell-Chance mechanism v ¼ VABðKiaKbþKbAþKaBþABÞ
Intersecting lines
Rapid equilibrium ordered sequential mechanism v ¼ VABðKiaKbþKbAþABÞ
Intersecting lines
Double-displacement mechanism v ¼ VABðKaBþKbAþABÞ
Parallel lines
Table 2. Rate expressions for different type of bisubstrate mechanisms.
Figure 6. Double reciprocal plot for double-displacement mechanism (at different levels of B).
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kinetic study also reveals which form of enzyme can exist and which cannot, which has
significant implications in the study of dead-end inhibition and therapeutic application
[68, 69]. The rapid equilibrium ordered mechanism is a unique sequential mechanism as the
chemistry step is the slowest step along the reaction pathway. This results in the absence of
kinetic term Ka[B] from the rate of expression.
v0 ¼
Vmax½A½B
KiaKb þ Kb½A þ ½A½B
(39)
This mechanism cannot be differentiated from other on the basis of double-reciprocal patterns.
1
v0
¼
1
½A
KiaKb
Vmax½B
þ
Kb
Vmax½A
þ
1
Vmax
(40)
As discussed previously, both the slope (KiaKb/Vmax[B]) and intercept (Kb/Vmax[B] + 1/Vmax)
terms reveal a dependency on the concentration of substrate B. In this instance, the graph of
intercept will not differ much. By contrast, the slope value (y = 1/[B](KiaKb/Vmax)) when plotted
as the slope versus 1/[B], a line that passes directly through the origin as Ka/Vmax does not exist.
However, the slope-of-the-slope value reflects free enzyme and is equivalent to KiaKb/Vmax.
Similarly, the implications are valid when bisubstrate reaction is studied by varying concen-
tration B at various levels of the concentration of A, are kept constant.
This distinctive character works as a diagnostic tool to distinguish rapid-equilibrium ordered
mechanism from all the other double-reciprocal plots. For various rate expressions for other
mechanism, please refer the above section. The double-displacement or ping-pong mechanism,
which represents the other type of bireactant mechanism, has symmetrical equation as it can
be broken into two separate equations representing each half of the complete reaction [70]. For
example, at saturating concentrations of substrate, the equation can be simplified as,
v0 ¼
Vmax½A
Ka þ ½A
at saturating concentration of B (41)
v0 ¼
Vmax½B
Ka þ ½B
at saturating concentration of A (42)
The diagnostic double-reciprocal pattern for a double-displacement mechanism is a series of
parallel lines. When varying the concentration of A, the double-reciprocal equation becomes,
1
v0
¼
1
½A
Ka
Vmax
þ ð
Kb
½B
þ 1Þ
1
Vmax
(43)
When the intercept of intercept is plotted, it provides the values of Kb/Vmax and 1/Vmax. By
contrast, the slope value from the primary plot is defined as y = (Ka/Vmax).
When reaction mechanism is predicted based on the initial velocity data, one has to be
sceptical as value of Kia is much greater than that of Ka, rapid-equilibrium random mechanism
gets degenerated into a rapid-equilibrium ordered mechanism. If the value of Kia is very less,
then the sequential mechanism degenerates into a ping-pong mechanism [11, 45, 55, 61].
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Examples
— Ternary complex mechanism
Cinnamyl acetate is a major ingredient of food and cosmetic products as a flavouring or
fragrance agent [71]. Yadav and Devendran [71] discuss transesterification of cinnamyl alcohol
with vinyl acetate to produce cinnamyl acetate. The parameters were optimized to minimize
the errors in the prediction of kinetic constants due to change in temperature and solvent
system. The mass transfer resistance was removed to accurately estimate the kinetic constant.
Hence, the reaction was conducted in toluene with 10 mg novozym 435 as a catalyst. The mole
ratio was maintained at 1:2 of cinnamyl alcohol to vinyl acetate. Under these optimized
conditions, the reaction kinetics was studied. The detailed experimental process is explained
in the section below. The kinetics was predicted by systematically changing the concentrations
of reactants on a wide range of the concentrations keeping others constant. The Lineweaver
Burk plot was plotted with the initial velocities of reaction (Figure 8). It was observed that for
given system under given set of conditions, reaction followed ternary complex mechanism as
the plot showed the lines intersecting with each other [71].
The formation of dead-end complex with alcohol at saturating level of cinnamyl alcohols is
observed in double reciprocal graph with linear increase in slope and intercept with rise of
concentration of cinnamyl alcohol (Figure 8). The equation obtained with this mechanism is
represented as,
v ¼
Vmax½A½B
ðKiaKmbð1þ ð½B=KibÞÞ þ Kmb½A þ Kma½Bð1þ ð½B=KibÞÞ þ ½A½BÞ
(44)
Where v is the velocity of reaction, Vmax is the maximum velocity of reaction and [A] and [B]
represent the initial concentration of vinyl acetate and cinnamyl alcohol, respectively. Kma and
Figure 8. Lineweaver Burk plot of initial velocity versus concentration of vinyl acetate.
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Kmb are the Michaelis constants for vinyl acetate and cinnamyl alcohol, respectively; Kia and
Kib are the inhibition constants for vinyl acetate and cinnamyl alcohol, respectively. The kinetic
constants were predicted using Polymath 5.1 software. The model was validated by plotting
the simulate versus experimental rate of reactions for proposed reaction mechanism.
Ping-pong Bi-Bi mechanism
The reaction between ethyl-3-phenylpropanoate and n-butanol was studied using novozyme
435. The reaction conditions of transesterification are optimized for maximum conversion and
initial rates to understand the kinetics and mechanism. There is synergism between enzyme
catalysis and microwave irradiation. The reaction kinetics was studied after eliminating the
external mass transfer limitation. The Lineweaver Burk plot showed that the lines are parallel
to each other. The reaction follows the ping-pong bi-bi mechanism with inhibition by
n-butanol as the double reciprocal graph represents the data in the form of parallel lines
(Figure 9) [72].
With experimental data analysis and Lineweaver Burk plot, the reaction rate equation was
predicted as,
v0 ¼
Vmax½A½B
Kmb½A þ Kma½Bð1þ
½B
Ki
Þ þ ½A½B
(45)
where Kma and Kmb are the respective Michaelis constants for ethyl-3-phenylpropanoate and
n-butanol. v0 and Vmax represent the respective initial and maximum velocity of the reaction.
The data are validated with a parity plot.
Figure 9. Lineweaver Burk plot of initial velocity versus concentration of ethyl-3-phenylpropionate.
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Ordered Bi-Bi mechanism
For the production of perlauric acid, Novozyme 435 was used as catalyst in toluene solvent.
The conversion and initial velocity are optimized with reference to the different parameter of
reaction. Lineweaver-Burk plots indicated the formation of a ternary complex. The reaction
undergoes ordered bi-bi mechanism based on which the kinetic parameters were calculated
(Figure 10) [73].
Reusability studies indicated that there was enzyme deactivation and from the preliminary
study of the deactivation, it was observed that the deactivation obeys a pseudo first-order
model. The deactivation was observed at higher levels of hydrogen peroxide wherein the
methionine and cysteine amino acid got oxidized due to the hydrogen peroxide. The ordered
Bi-Bi mechanism showed the best fit for the given data and it is represented as,
v ¼
Vmax½A½B
ðKiaKmbð1þ ð½B=KibÞÞ þ Kmb½A þ Kma½Bð1þ ð½B=KibÞÞ þ ½A½BÞ
(46)
Some of the examples for the bisubstrate reaction are presented in Table 3.
2.2.3. Termolecular reaction
Termolecular reactions are the reactions wherein three reactants react simultaneously to form a
desired product. They are unusual because the simultaneous collision of three molecules is a
rare event. Fourth and higher-order reactions are unknown. These types of reaction are given
in literature [74].
Figure 10. Lineweaver Burk plot of initial velocity versus concentration of lauric acid.
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3. Enzyme inhibition
The inhibition of enzymes is a naturally occurring phenomenon that control and regulate
body’s defence and repair system along with various other essential functionalities. It also
helps in regulating the optimal use of limited resources available within the cell. Naturally
occurring inhibition processes are blood coagulation, blood clot dissolution, complement
activation, connective tissue turnover, inflammatory reaction, etc. [57]. Hence, it is very essen-
tial to study the nature of inhibitor, mode of action, quantitative estimation of the inhibitory
effect of the inhibitor on the enzyme. Such mechanistic and kinetic observations provide the
information for the designing of various inhibitors. The inhibitors are usually classified into
two groups namely, reversible and irreversible. In case of reversible, inhibitors bind with the
Sr. no. Enzyme Reaction Kinetic model Inhibiting molecule Reference
1. Mucor Miehei
lipase
Esterification of pentanol
with caprylic acid
Ping-pong Bi-Bi
mechanism
n-Pentanol [66]
2. Candida
antarctica
lipase B
Reaction of citronelly
alcohol and vinyl acetate
Ping-pong Bi-Bi
mechanism
Both citronelly alcohol
and vinyl acetate
[28]
3. Candida
antarctica
lipase B
Reaction of n-butyl amine
with benzyl acetate
Ternary complex
mechanism
n-butyl amine [77]
4. Candida
antarctica
lipase B
Esterification of cinnamyl
alcohol with lauric acid
Ternary complex
mechanism
Cinnamyl alcohol [78]
5. Candida
antarctica
lipase B
Resolution of (RS)-methyl
mandelate
Ordered Bi-Bi
mechanism
S-methyl mandelate [79]
6. Candida
antarctica
lipase B
Esterification of butyl
alcohol and levulinic acid
Ternary complex
mechanism
Levulinic acid [80]
7. Candida
antarctica
lipase B
Reaction of Styrene with
perlauric acid
Ternary complex
mechanism
Lauric acid [81]
8. Candida
antarctica
lipase B
Transesterification of n-
octanol with vinyl acetate
Ordered bi-bi
mechanism
n-octanol [17]
9. Candida
antarctica
lipase B
Reaction of (DL)-(+/)-3-
phenyl lactic acid with
vinyl acetate
Ordered bi-bi
mechanism
(DL)-(+/)-3-phenyl
lactic acid
[27]
10. Candida
antarctica
lipase B
Reaction of (+/)-1-(1-
naphthyl) ethanol with
vinyl acetate
Ping-pong Bi-Bi
mechanism
Inhibition by both
substrate
[82]
11. Candida
antarctica
lipase B
Hydrolysis of methyl
mandelate
Ordered bi-bi
mechanism
(RS)-methyl mandelate [83]
Table 3. List of bisubstrate reaction with their mechanism and inhibition.
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enzyme with non-covalent interaction which can be reversed at any point of time by dilution
or dialysis. In second class of inhibitors, i.e. irreversible inhibitors, the inhibitors bind cova-
lently or tightly with the enzyme which cannot revert back causing permanent damage to the
catalytic site [68, 75, 76]. The detailed classification of the inhibition is shown in Figure 11.
3.1. Reversible inhibition
The reversible inhibition is the class of inhibitors which bind with the enzymes and this
binding can be reversed with the complete regain of enzyme activity. The reversible inhibition
further is mainly classified in three categories competitive, uncompetitive and non-competitive
inhibition based on its binding with direct enzyme, enzyme-substrate complex or both [77].
3.1.1. Competitive inhibition
The competitive inhibition occurs due to either binding of substrate or inhibitor to the active
site. Both substrate and inhibiting molecule compete for the same active site on the enzyme
leading to the reduction in the velocity of the reaction. The diverse set of substrate analogues
studied for their activity in the presence of different kinds of inhibitors reveals immense
information useful to understand the interaction of the active site and catalytic mechanism of
the enzyme. The basic assumption in the study of this type of inhibition is that the inhibitor can
only bind to the active site of the free enzyme [3, 74, 78].The Cleland notation for the compet-
itive inhibition can be written as,
Eþ A⇄
k1
k2
EA!
k2
Eþ P
þ
I
↑↓
EI
(47)
which can also be represented as,
Figure 11. The classification of enzyme inhibition.
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Aþ E⇄
k1
k1
EA!
k2
Eþ P (48)
Eþ I⇄
ki
EI (49)
The Michealis Menten equation for the competitive inhibition can be written as,
v ¼
Vmax½S
½S þ Kmð1þ
½I
Ki
Þ
(50)
Hence, the Lineweaver Burk equation can be derived as,
1
v
¼
ð1þ ½I
Ki
ÞKm
Vmax½S
þ
1
Vmax
(51)
After plotting 1/v versus 1/[S], the slope and intercept will give the values of apparent Km and
Vmax (Figure 12).
In this case, Km changes with Vmax unchanged. Increase in KM depends upon the concentration
of I. The competitive inhibitors can be applied as targeted blockers of enzyme in the pharma-
ceutical industry. Product can also act as a competitive inhibitor in various regulation pathways
in the cells which increases the efficiency of cellular processes by eliminating the accumulation
product and diverting the substrate to another pathway [79]. Both structural analogue and in
some cases, unrelated compounds act as competitor inhibitors. For example, alkaline phospha-
tases are inhibited by the inorganic inhibitors where both substrate and inhibitor have similar
affinities. Because of high selectivity, it provides many in vivo application opportunities, e.g.
penicillinase, prostaglandin cyclooxygenase.
Figure 12. Graphical representation of competitive inhibition.
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The reactions requiring the presence of metal ion as co-factors compete with similar ones for
the catalytic site on the enzyme, e.g. Ca ions compete with Mg requiring enzyme. Similarly, Na
requiring enzymes are inhibited by the Li and K ions. In double-displacement reaction mech-
anism, high concentration of the second substrate acts as a competitive inhibitor with reference
to binding of first substrate, e.g. aminotransferase.
Adulteration of ethanol with methanol makes it unsuitable for human consumption, com-
monly known as denatured alcohol. Methanol is oxidized in liver and kidney to form formal-
dehyde and formic acid. This causes damage to retinal cells that may cause blindness which is
followed by severe acidosis which lead to death. This may also lead to depression of CNS.
Retardation of first step in oxidation of methanol can be achieved by administration of ethanol.
The removal of methanol is done by gastric lavage, haemodialysis and administration of
exogenous bicarbonate. Ethylene glycol is an anti-freezing agent used in automobiles. Inges-
tion in the body leads to depression of CNS and causes metabolic acidosis with severe renal
damage after oxidation by alcohol dehydrogenase which is inhibited by ethanol or 4-methyl
pyrazole. Kidney damage is resulted due to the deposition of oxalate crystal into convulsed
tubules. Elevated anion-gap metabolic acidosis is caused by glycolic acid and lactic acid. The
shift in redox potential causes the production of lactic acid instead of pyruvate. The treatment
is same as that of methanol adult injection. Fomepizole drug (4-methylpyrazole) can be used in
the treatment without any side effect that is caused by the ethanol. Isopropanol is major
constituent in rubbing alcohols such as hand lotion and anti-freezing preparations. If ingested
accidentally is oxidized and converted into acetone, a toxic non-metabolized product by
alcohol dehydrogenase. It also causes depression in CNS, coma, gastritis, vomiting and
haemorrhage. This can be treated by haemodialysis.
Toxicity by these substrates is done by evaluation of following serum components: Na, K, Cl,
HCO3, glucose, urea nitrogen, blood osmolality, blood gap, anion gap and metabolic acidosis
along with pertinent medical history. Serum osmolal gap is difference between measured
osmolality and calculated osmolality.
Serum osmolal gap = Measured osmolality-calculated osmolality
Calculated osmolality=2  Na+ (mM/L) + glucose (mM/L) + Urea nitrogen (mM/L)
Small rise in toxic substances increase osmolality significantly. Hence, it becomes very easy to
detect the toxicity in the body based on this test.
3.1.2. Uncompetitive inhibition
Uncompetitive inhibition occurs when instead of enzyme, inhibitor binds with enzyme
substrate complex to inhibit the reaction. The binding of inhibitor is possible only after the
binding of substrate to the enzyme. The binding site of the inhibitor forms when the
substrate binds with enzyme. This type of inhibition is rare where inhibitor binds with
the enzyme substrate complex [7, 52]. This can be represented in the form of Cleland
notation as,
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Eþ A⇄
k1
k2
EA!
k2
Eþ P
þ
I
↑↓
EAI
(52)
can also be represented as,
Aþ E⇄
k1
k1
EA!
k2
Eþ P (53)
EAþ I⇄
ki
EAI (54)
The Michealis Menten equation for the uncompetitive inhibition becomes,
v ¼
Vmax½S
Km þ ½Sð1þ
½S
Ki
Þ
(55)
The Lineweaver Burk equation can be written as,
1
v
¼
Km
Vmax½S
þ
ð1þ ½I
Ki
Þ
Vmax
(56)
The plot is shown in Figure 13.
Figure 13. Graphical representation of uncompetitive inhibition.
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The binding with ES complex yields parallel lines wherein both slope and intercept change.
The apparent Km and Vmax include division by (1+ [I]/Ki). This type of inhibition is rarely
observed in single substrate reactions. The classical example of this type of inhibition is an
intestinal alkaline phosphatase which is inhibited by l-phenylalanine.
3.1.3. Non-competitive inhibition
Non-competitive inhibition is observed when inhibitor can bind with both enzymes and
enzyme-substrate complex. The inhibitor bears no structural resemblance to substrate and
bind to distinct site than the substrate. There is no competition between substrate and inhibitor
for the active site of the enzymes. This type of inhibition cannot be overcome by increasing the
substrate concentration. This may bind to enzyme or enzyme-substrate complex making both
of them catalytically inactive [8, 80]. This can be denoted as,
Aþ E⇄
k1
k1
EA!
k2
Eþ P (57)
Eþ I⇄
ki
EI (58)
EAþ I⇄
ki
EAI (59)
The Cleland notation is denoted for the non-competitive inhibition.
Eþ A⇄
k1
k2
EA!
k2
Eþ Pþ I⇄EI þ I⇄EAI (60)
The double reciprocal plot for the non-competitive inhibition is represented in Figure 14.
Examples:
• Enzymes with sulfhydryl group that participate in maintenance of three-dimensional confir-
mation of the molecules are non-competitively inhibited by heavy metal ions such as silver
(Ag), lead (Pb) and mercury (Hg).
ESH þHgþ2 ⇄ ESHgþ þHþ (61)
Heavy metal ions react with S-, O- and N-containing ligand. Hence, they can inhibit enzymes
in the metabolic pathway (see Table 4).
3.2. Irreversible inhibition
Irreversible inhibition occurs, when inhibitor molecule bind with enzyme so strongly that it
does not dissociate from the enzyme. This kind of inhibitor binds rapidly with the enzyme and
deactivated the enzyme completely. The activity decreases exponentially with binding of the
inhibitor, at saturating levels of inhibitor concentration. At lower concentration, the rate of
reaction decreases linearly. The covalent modification and tight binding (Kd< 10
8 M) are two
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types of irreversible inhibitions; for practical purposes, there is no dissociation of E and I. Thus,
physical separation processes are ineffective in removing the irreversible inhibitor from the
enzyme [33, 75, 81]. Reaction is written as,
Eþ I⇄
k1
k1
EI!
k2
EI (62)
3.2.1. Transition state analogues
Transition state is a state in which substrate is strongly bound and interacting with enzyme for
short period (in picosecond). Therefore, the transition state analogues bind tightly with transi-
tion state enzyme and cannot be easily dissociated from the enzyme [82–84, 94, 102, 103,
104, 105]. The rate expression for such type of inhibition is represented as,
Et ¼ Ee

k2 ½I
½Iþki (63)
3.2.2. Suicide inhibition
The suicide substrate binds covalently with an active site of the enzyme and blocks the enzyme
completely. The mechanism of binding of suicide substrate with the active site of the enzyme
gives the understanding of enzyme mechanism [84–86].
Eþ I⇄
k1
k1
EI!
k2
EI!
k3
Eþ I
↓kþ4
E I
(64)
Figure 14. Graphical representation of noncompetitive inhibition.
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Sr.
no. Enzyme Substrate Inhibitor Mechanism of action Reference
Competitive inhibition
1. Cytochrome c
oxidase
Oxygen Cyanides Competes with active site [92]
2. Succinate
Dehydrogenase
Succinate Malonate, oxaloacetate,
oxaloacetate
Competes with active site [93, 94]
3. HMG-CoA
reductase
HMG-CoA Lovastatin Competes with active site [54]
4. Sucrase Sucrose Acarbose, nojirimycin, and
deoxynojirimycin
Competes with active site [95]
5. Influenza
neuraminidase
Neuraminic acid Oseltamivir carboxylate Competes with active site
and prevent escape of viral
flu particles (Influenza)
[96, 97]
6. Dihydropteroate
synthetase
p-Aminobenzic
acid
Sulfonamides Competes with active site
(bacterial infection)
[98]
7. Dihydrofolate
reductase
Folate Methotrexate Competes with active site
and prevent rapid DNA
synthesis (HIV)
[98]
8. Xanthine oxidase Hypoxanthine Allopurinol Competes with active site to
block formation of uric acid
(Gout, hemotological
disorders, antineoplastic
therapy)
[99, 100]
9. Cytochrome P450
enzyme
Range of
substrate
Biapigenin (hypericum
perforatum extracts)
Competes with active site [101]
Non-competitive inhibition
1. Porphobilinogen
synthase and
ferrocene lactase
Heme group
synthesis
pathway
Lead (Pb) Bind with sulfuryl group of
enzyme
[102, 103]
2. Enzyme requiring
divalent ions
Magnesium and
calcium
Ethylenediamine tetracetate
(EDTA)
Chelates the metallic ion [104]
3. Enolase
(magnesium and
manganese
complexes
2-
phosphoglycerate
Fluorides Competes with magnesium
and manganese complexes
and prevent glycolysis
pathway.
[105, 106]
4. Acetylcholinesterase Acetylcholine cis-2-
dimethylaminocyclohexanol,
(hydroxyphenyl)-
trimethylammonium
derivatives
Binds with esterase active site [107]
Uncompetitive inhibition
Inositol
monophosphatase
Inositol Lithium Interfere with
polyphosphoinositide
metabolism in brain
[108, 109]
Table 4. List of examples of different types of inhibitions.
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Examples:
• Enzymes containing free sulfhydryl group at active site of the enzymes. These groups react
with alkylating agent such as iodoacetic acid. This cause inactivation of enzymes. Imidazole
ring also showed the reactivity with the iodoacetic acid, e.g. Ribonuclease, two residue
Histidine 12 and Histidine 19 loses activity by reacting with iodoacetic acid at pH 5.5 [8].
• Seryl containing hydroxyl group at active site modified by organophosphorus diisopropyl
phosphate fluoridate (DFP) and it inactivates serine hydrolase. Acetylcholine esterase has
two types of active sites: (1) esteric activity: site contains Seryl OH sites whose nucleophi-
licity has been enhanced by properly placed imidazolium group. Generally, function as
base catalyst (2) site containing negative charges. The seryl hydroxyl site reacts with DFP
and inactivates its activity. The inhibition of acetylcholine esterase can be reversed and
enzyme can be reactivated. The reactivation by hydrolysis is very slow. Therefore, nucle-
ophilic reagents such as hydroxyl amine, hydroximic acid and oximes can reactivate
enzyme more rapidly [87].
• In activation and deactivation of cytochrome oxidase, cyanides are most rapidly acting toxic
substances. It inhibits intracellular respiration and causes tissue hypoxia by binding to termi-
nal component of mitochondrial electron transport chain. This chain uses molecular oxygen
to generate energy. Cyanides severely impede mitochondrial respiration. It causes cell death
and affects CNS and respiratory system. It is an oxidized form of cytochrome oxidase has
high affinity for CN forms and loses complex with Fe+2of porphyria which forms stable
complex with negative cyanides ions. It prevents oxygen uptake, e.g. methemoglobin [88].
• Proteinase inhibitor and their applications: Mostly, proteinases are proteinaceous in
nature. They are present in intracellular and extracellular fluids in the form of enzymes
and peptides. Other protein inhibitors are very rare. Within the cells, it contributes in the
control of blood clot, activation of complement cascades, formation and destruction of
peptide hormones. Protein inhibitor combines with target proteinase. It converts then into
non-dissociable form. It binds to reactive or/and active site. Specific amino acid is recog-
nized as primary binding site. For example, elastase is inhibited by alpha-1 protein
inhibitors, which inhibit serine-containing proteinase. Alpha-2 macroglobins are present
in plasma of mammals. It can combine with the variety of proteinase. It only inhibits
proteolytic enzymes acting towards large protein. It is very useful in metastasis of cancer.
It requires remodelling of extracellular matrix (ECM). Viral proteinase offers unique target
HIV protease inhibitors. Reverse transcription of RNA to dsDNA is inhibited by nucleo-
side analogue such as zidovudine, didanosine, zalcitabine, stavudine and lamivudine.
After integration, it produces protease, i.e. aspartly protease, which is a homodimer
cleaves at phenylalanine-proline bonds and is observed in mammals [88] (see Table 5).
3.3. Inhibition in combination with each other
The kinetics expression for mutually exclusive inhibitors is studied for single substrate system.
The overall reaction velocity for the system in presence of types of inhibition is given by,
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1v1,2,…n
¼
Xn
i¼1
1
vi

n 1
v0
(65)
Wherein, v0 is the velocity in the absence of inhibition and ‘n’ is the number of inhibitors used
in combination. Similarly, the kinetic expression is derived for the two substrate systems. For
example, two substrate reaction with two inhibitors: ping-pong Bi-Bi mechanism.
Two inhibitors: I1 is competitive with respect to the substrate A (binds to E) and uncompetitive
with respect to the substrate B; I2 is competitive with respect to the substrate A (binds to E) and
uncompetitive with respect to the substrate B.
1
v0
¼
ðABþ KbAþ KmBÞ
VAB
(66)
1
v1
¼
ðABþ KbAþ KmBð1þ
I1
KI1
ÞÞ
VAB
(67)
1
v2
¼
ðABþ KbAþ KmBð1þ
I2
KI2
ÞÞ
VAB
(68)
1
v1,2
¼
ðABþ KbAþ KmBð1þ
I1
KI1
þ I2
KI2
ÞÞ
VAB
(69)
Sr.
no. Enzyme Substrate Inhibitor
Mechanism of
action Reference
1. ATPase Phosphoenolpyruvate,
ATP
Rutamycin, bongkrekic acid Tight binding
inhibitions
[116]
2. Human mast-cell tryptase Benzamidine CRA-001390 inhibitor Tight binding
inhibitions
[113]
3. Adenosine deaminase Adenosine (purine
metabolism)
Deoxycoformycin, 1,6-
dihydro-6-hydroxymethyl
purine ribonucleoside
Tight binding
inhibitions
[117]
4. Human caspases Proteins Peptide based (4 amino acid
sequence)
Tight binding
inhibitions
[118]
5. Serine proteases Proteins Phenylmethanesulfonyl
fluoride
Suicide inhibition [36]
6. Thymidylate synthase and
Cofactor methylene
tetrahydrofolate
Deoxyuridine
monophosphate
Fluorouracil Suicide inhibition [36]
7. Chymotrypsin Protein Tosyl phenylalanyl
chloromethylketone
Suicide inhibition [119]
8. Monoamine oxidase
(MAO)
Norepinephrine,
serotonin
Clorgyline, deprenyl,
pargyline
Suicide inhibition [120]
9. Cyclooxygenase 2 Arachidonic acid Vioxx, celebrex Suicide inhibition [121–123]
Table 5. Examples of irreversible inhibitions.
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Overall velocity of the reaction is given as,
1
v1,2
¼
1
v1
þ
1
v2

1
v0
(70)
Synergism:
1
v1,2
〉
1
v1
þ
1
v2

1
v0
(71)
Antagonism:
1
v1,2
〈
1
v1
þ
1
v2

1
v0
(72)
The expression is useful to understand the effect of inhibitors on each other’s activity when
used in combination. The overall velocity of the reaction is independent of mechanism of
reaction, type of inhibition and number substrate used in the study [89].
4. Analytical aspects of enzyme inhibition
4.1. Assay conditions for single substrate enzyme kinetics
To estimate the reaction rate, it becomes very essential to quantify accurately the change in the
concentration of either substrate or product or both during the progress of reaction. If the
substrate and product generate different signals, the spectroscopic techniques like UV-visible
spectroscopy and fluorescence spectroscopy can be applied to estimate these parameters [90].
If there is no significant difference between the products and substrate signal, then the better
alternative is a discontinuous assay which measures the rates by intermittent sampling. This
sampling can be done with removal of aliquots of a reaction mixture or sampling from the
batch reactor. These reaction samples represent the time points of a reaction, and their respec-
tive concentration of product formed and substrate consumed. In some cases, labelling the
molecules with chromophore or the fluorescent dye can serve as a better option. The estima-
tion of amount of an ATP can be quantified by determining the amount of Pi present by the
Malachite Green assay with absorbance at 660 nm [91]. Chromatography techniques can
separate the substrate from the product which is then estimated with the spectroscopic method
in continuous or discontinuous manner. In depth understanding, the enzyme mechanism is
studied by radiolabelling the substrate, which is tracked for the transition of substrate through
intermediate state to the product during the reaction progress [92]. The crystallographic struc-
tures of separated intermediate complexes and the various states of enzymes during the
reaction progress reveal most of the mechanistic aspect of the reaction. With the advent of
instrumentation technology, the product can be separated or analysed by thin-layer chroma-
tography, separation techniques such as high-performance liquid chromatography, electropho-
resis and gel filtration. The high-performance liquid chromatography is the most applied
system as it gives the separation and quantification of substrate as well as product in real time.
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Recent studies showed that the mass spectrometric (MS) techniques are applied to study the
conversion of substrate into product and their behaviour in the presence of modulators.
Matrix-assisted laser desorption ionization-time of flight-mass spectroscopy (MALDI-TOF-
MS) is proved as more effective technique when compared to other mass spectrometric tech-
niques, such as electronspray ionization MS, as it showed negligible interference due to the
presence of buffers and reagents. MALDI-TOF-MS can quantify the ratio of substrate to
product form. Greis et al. studied the phosphorylation catalysed by kinases using this tech-
nique for accurate prediction of the kinetics of reaction [93]. This technique has been used in
combination with various chromatographic techniques such as capillary isoelectric focusing,
frontal affinity chromatography and size exclusion chromatography to analyse the inhibition
of the enzyme in direct or indirect manner [93–96]. This method is free of laborious work of
labelling or derivatization and can be done in short period of time.
To estimate the enzyme inhibition and relative kinetic parameters, the stepwise process has to
follow with the aim of minimum human error, which is discussed in the following sections.
4.1.1. Experimental measurement of Vmax, kcat, and Km
As discussed in the above sections, the quantification of the initial velocity, the region of the
curve wherein velocity does not change with time (up to 10% of the conversion), is of prime
importance to estimate the reaction kinetics under the influence of other factors such as
product inhibition. This region varies with the type of enzyme, nature of substrate and
medium conditions and type of modulator. Hence, for any given system, it cannot be pre-
determined. The instrument capacity needs, therefore, has to be very precise and effective to
detect the signal generated from the build-up of product and to plot it. As the measurement
needs to be done at a very constrained range, it may severely compromise on measurements
because of the poor instrument capacity.
The linear range for the product of an instrument can be estimated by measuring the response
of product at various known concentration and preparing the standard curve. Before the start
of experimentation for evaluating enzyme kinetics, it is very essential to optimize the condi-
tions of the reactions so that the enzyme remains stable throughout the reaction progress. If the
maximum plateau value of product formed does not reach the same for all levels of tested
enzyme, it is likely due to the enzyme instability over time [10, 53].
Conditions required for measuring initial velocity of an enzyme reaction:
• Equilibrate and maintain all the reaction reagents to the optimum temperature.
• Keep the reaction medium condition static (previously optimized or derived from litera-
ture) for the optimum performance of enzyme.
• Replicate the same reaction for minimum three times to avoid the manual errors.
• Proper analytical technique is developed for the estimation of product formed or substrate
consumed below 10%.
• Record the signal of the reaction mass at time zero for the background.
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For kinase assays, generally, the background can be recorded without the enzyme or the sub-
strate. The condition with highest background level should be used for further estimation of the
parameters. In case of EDTA, background is taken with control without EDTA during validation
of a kinase assay. Once the assay has been validated, if the background measured with EDTA is
the same as that of no enzyme and no substrate control, then EDTA could be used.
Measurement of Km and Vmax
After primary experiments, wherein the initial velocity conditions have been established and
change in velocity with respect to time has been estimated, the substrate concentration should
be varied. These data will generate a saturation curve and can be used for the determination of
Km and Vmax values. The Michaelis Menten kinetic model shows that the Km = [S] at Vmax/2. In
order for competitive inhibitors in which the substrate competes, the substrate concentration
should be maintained around or below the Km. At the substrate concentration higher than the
Km, the identification of competitive inhibitors itself becomes more difficult.
For kinase assays, two set of experiments are carried out. In first experiment, the Km for ATP is
determined at saturating levels of the substrate concentration. Subsequent reactions need to be
conducted with optimum ATP concentration (around or below the Km value). However,
simultaneous determination of Km for ATP and specific substrate gives more accurate estima-
tion of kinetic constants with maximum information and any potential co-operativity between
substrate and ATP [91]. To achieve steady state, ratio of substrate to enzyme is maintained in
between 100 and one million.
How to measure Km
• Minimum eight experiments should be conducted with various substrate concentrations
from 0.2 to 5.0 Km (from the literature, if available).
• The initial estimate is established by using the wide range of six substrate concentrations
when no data are available in the literature. This is then followed by the first step.
• For bisubstrate reaction, the Km of the substrate of interest is measured in replicates by
keeping the other substrate at saturating concentrations and vice-versa.
• The data are fitted in rectangular hyperbola function using non-linear regression analysis.
The reaction product is measured at various times for eight different levels of substrate. The
product generated (Y-axis) is plotted against the reaction time (X-axis) with each curve of different
concentration of substrate. The slope of the line is the initial velocity (v) of the reaction curve.
These resulting initial velocities (Y-axis) are plotted against the concentration of substrate (X-
axis) and fitted with a non-linear regression analysis in a rectangular hyperbola (Figure 2). The
Km is one-half the maximum velocity determined under saturating substrate concentrations.
The linear plots are generated to determine the kinetic constants besides fitting the data by
non-linear regression such as Lineweaver–Burk plot wherein the reaction rates (1/vo) are
plotted against reciprocal substrate concentrations (1/[S]) with y-intercept equivalent to 1/
Vmax; and the slope of Km/Vmax. Various linearization plots such as Eisenthal–Cornish–Bowden
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plot, Dixon plot and Hanes plot can also be used to estimate kinetic and inhibition constant
(see Section of Enzyme Kinetics).
Optimization experiments
Published literature information should be used in selecting these factors. The following
parameters should be optimized prior to kinetic study so that the enzyme remains stable
throughout the experiments.
• Divalent cations, for example Ca2+, Mg2+, Mn2+
• Salts, for example NaCl, KCl
• Reducing agents, such as β-ME, DTT and glutathione
• Bovine serum albumin
• Detergents, such as Triton, CHAPS and DMSO
• Buffer source, for example HEPES versus acetate buffer
• pH
The assay conditions should be validated to avoid the loss of enzyme activity due to the wrong
selection of buffer, pH or temperature [97].
4.2. Assay conditions for bisubstrate reaction
The plotting of Lineweaver Burk plot is more important to distinguish between a sequential
reaction mechanism (plotted lines intersect each other) and a double-displacement or ‘ping-
pong’ kinetic mechanism (plotted lines remain parallel). In some cases, these graphs gave
preliminary evidences in different types of sequential kinetic constants. In the process of
predicting kinetic and inhibition constant for the bisubstrate reaction, it is compulsory to
understand the mechanism of the reaction to predict the appropriate rate equations. The data
were generated by plotting the reciprocals of the initial rate of product formation versus [A] at
the differing [B] and vice-versa. Most importantly, the values of kinetic parameters such as Km
and Vmax change for substrate A with the change in substrate B concentration [12, 41, 63]. In
case of random sequential reaction, the double reciprocal plot of rate expressions gives the
apparent value of slopes and intercept which include the term for concentration B.
1
v0
¼
1
½A
KiaKb
Vmax½B
þ
Kb
Vmax
 
þ
Ka
Vmax½B
þ
1
Vmax
½B ¼ constant (73)
The double reciprocal plot gives the confirmation of the mechanism followed by the reaction.
But, as the slope KiaKb
Vmax½B
þ Kb
Vmax
 
and intercept Ka
Vmax½B
þ 1
Vmax
 
terms involve the concentration
term, it signifies the dependency on the concentration B. Also, it is noted that the slope and
intercept are the linear equations and can be plotted against 1/[B]. When the intercept is plotted
against 1/[B], it gives the values of 1/Vmax and Ka/Vmax and this plot is called as intercept of
intercept (Figure 15). At different concentration of substrates various different forms of
Enzyme Inhibitors and Activators106
enzyme exist in the system. To obtain the intercept of intercept of the secondary plot, concen-
tration of both A and B are maintained at higher concentrations which give rise to higher
concentration of EAB Form.
To calculate the Ka/Vmax of desired enzymatic reaction, the EA form of enzyme should be
predominant. Hence, the slope of the intercept is calculated by maintaining the concentration
of A at high levels while concentration of B is kept low. The plot of slope versus 1/[B] will give
the values of Kb and Kia, which are measured graphically (Figure 16).
Figure 15. Secondary plot of intercept versus reciprocal of concentration of B.
Figure 16. Secondary plot of slope versus reciprocal of concentration of B.
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Similarly, same kind of analysis can be performed to find out the Vmax and Kb/Vmax by keeping
high levels of B and A. The plot of intercept of intercept, i.e. intercept versus 1/[A], will give the
values of 1/Vmax and Kb/Vmax. The slope plotted against the 1/[B] was studied for deriving the
values of Ka and Kib by analysing at high levels of B and low concentrations of A (building up
the concentration of EB). These secondary plots elaborate various aspects of enzyme kinetics
some of which are discussed in the kinetics section.
4.3. Software used in kinetic data analysis
The data-fitting process can be accomplished by using a software program that provides non-
linear regression-fitting capability. Various programs such as Kaleidagraph are developed
wherein the user put the experimental data along with probable fitting function for the
prediction of rate constants. Some other software such as dynafit, mathematica, sigmaplot
and prism are applied for the estimation of rate expression and effect of inhibition or activator
on the enzyme [98]. Alternatively, some of the programs like Enzfitter have a predefined
library of equations which can also be used for the prediction kinetics of enzyme. While using
the software for data prediction, one should be able to differentiate in errors added due to the
lack of fit and pure error as they contribute as a source of error [99]. Although both sources of
error normally contribute to the sum of squares of deviations from a model, they can be
separated. The inconsistencies between replicate observations are unaffected by the choice of
model and thus allow calculations of how much of the total sum of squares is due to the pure
error, and from this one can calculate the contribution of lack of fit [57, 80, 100].
The basic assumption during the development of related software is that the rate of reaction is
zero in the absence of substrate. The buffer solution used for the reaction should be selected so
that the pKa is not greater than 1 unit of pH that the desired one. Generally, the operational pH
should be less than pKa. This will maintain the desired configuration required for the optimal
activity of the enzyme. Also, the used buffer system should not react with the enzyme used for
the catalysis or the buffer interfering with the analysis method [10, 52, 88]. Primary assump-
tions that any developed software have done are as follows:
1. Enzyme to substrate interaction ratio is maintained as 1:1.
2. Inhibitor compete with enzyme active site/or active groups at enzyme allosteric site to
form enzyme-inhibitor-substrate and/or enzyme-inhibitor complex.
3. The loss of active free energy decides the formation of enzyme-inhibitor-substrate com-
plex.
4. Reaction is reversible at every stage of the interaction between enzyme-substrate, enzyme
inhibitor and enzyme-substrate-inhibitor interaction.
5. The binding of inhibitor or substrate with enzyme is expressed in terms of kinetic con-
stants of a catalytic reaction.
6. The physiological conditions such as pH, temperature, concentration of reactants and
reaction period are kept constant while determining the kinetic constants.
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7. The overall enzyme reaction rates and mode of inhibition are depended upon the
intermolecular forces between enzyme subunits, substrate or inhibitor.
While deriving the kinetics and mechanistic parameters in appropriate conditions at various
points in iterative manner, various well established programs make some primary assumption
during the development of the rate expression. For example, the popular program sigmaplot
can fit Michaelis-Menten data very easily, but if used in its default state it incorporates
assumptions that: (1) the errors in the observed rates are subjected to a normal (Gaussian)
distribution and substrate concentration are exactly known; and (2) all of the rates have the
same standard deviation and are independent of each other as magnitude of error in one rate
measurement do not affect the measurement of any other rate.
Some of the assumptions like no deviation in standard deviation cause the problem that need
to be eliminated from the model. Very less number of software databases allows doing so.
Hence, the selection of the software to process the data has to be done very meticulously. It is
always preferable to derive the rate expression and related constant manually with desired set
of assumptions for error free fitting of data which may be crossed checked with the computer-
ized data fitting. The computer-based data fitting serves as boon to researchers when more
complex and complicated rate expression are observed (e.g. bisubstrate reaction with inhibi-
tion and termolecular reactions). In the gist, software-based studies of kinetics become essen-
tial part of the system [2].
5. Design of inhibitors and activators
The use of inhibitors usually has two outputs when used against the target enzyme as drug.
First, the inhibition of enzyme leads to the accumulation of substrate that it meant to process
and second wherein the concentration of metabolite decrease as the enzyme is inactivated by
the presence of inhibitors. The inhibition of enzyme results into accumulation of the substrate
or the metabolite which then can be detected by the various analytical methods [101]. The
reduction of the metabolite due to inhibition of the selective enzyme from the pathway leads to
the blocking of further activation sequence and therefore the consequences are resulted due to
the same. For example, allopurinol inhibits the action of xanthine oxidase in the treatment of
gout disease while inhibition of co-enzymes in the pathway leads to the prevention of
undesired cancerous growth. The combination of two inhibitors may work in synergism or
may not. It has to be studied thoroughly before using it for the human treatment. Most of the
anti-cancerous and antibacterial drugs (e.g. cotrimoxazole) are used in synergism to fight
against the targeted disease. Some of the inhibitor (e.g. 5-fluorouracil and doxorubicin) acts
on the enzyme-co-enzyme complexes and DNA-enzyme complexes to form dead-end complex
instead of binding to the enzyme [85, 102, 103]. Other specific inhibitors can be described in
several forms including:
1. Coenzyme inhibitors: e.g. cyanide, hydrazine and hydroxylamine that inhibit pyridoxal
phosphate, and, dicumarol that is a competitive antagonist for vitamin K.
2. Inhibitors of specific ion cofactor: e.g. fluoride that chelates Mg2+ of enolase enzyme.
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3. Prosthetic group inhibitors: e.g. cyanide that inhibits the heme-prosthetic group of cyto-
chrome oxidase.
4. Apoenzyme inhibitors that the molecules which attack the apoenzyme component of the
holoenzyme and
5. Physiological modulators of reaction such as pH and temperature denature the enzyme
and disturb the catalytic activity drastically.
5.1. Rational approach to the design of enzyme inhibitors
5.1.1. General discovery method for lead inhibitor
A lead inhibitor with low potency and selectivity acts as a base scaffold molecule for designing
the highly potent and selective inhibitors. The pool of initial molecule (5000–10,000 related
compounds) to screen as a lead compound can be decided by two ways. Either by studying the
existing drug molecules creating side effects by reacting with proposed enzyme or from the
compounds having low potency in pharmacological, anti-bacterial, anti-parasitic, or anti-viral
effects in the screening experiments against the proposed target enzyme.
The selection of molecules to study for primary screening of lead compound can be decided on
the basis of prior knowledge of (1) modification of the structural scaffold of a lead inhibitor, (2)
information of substrate enzyme and inhibitor interactions and their catalytic mechanism and
(3) use of molecular modelling software. Among this pool, the compounds are then studied for
their inhibitory action. The molecules showing dissociation constant less than 1 μM against the
desired enzyme are designated as lead compound. These molecules are then studied with
various permutation and combination of approaches to enhance their activity against the
selective target. Some of the approaches that can be used for the redesigning of the molecules
are replacing existing functional group, enhancing the hydrophobic characters, removal of
steric hindrances as well as stereogenic centres. While applying the approaches, it needs to
understand the solubility of the drug molecule and its adsorption within the body. After
modifications, if the selected molecules are designed with the intent of pharmaceutical appli-
cations, then they tested and studied on the animal model. After clearing the animal studies, it
the molecules fail in the clinical trials, it requires further structural and manipulation of to
improve in vivo profiling [55].
5.1.1.1. Process of development of lead inhibitor
The complementary structure of the molecule to the active site of the enzyme forms non-
covalent bonds such as hydrogen bonds, ionic bonds and hydrophobic interaction to bind
with the enzyme. The structure specific requirements of the molecules are maintained by
replacing the isosteric replacement of groups. Isosteric replacement is done by replacing the
atoms or the group with similar electronic and steric configurations which can be the elements
within the same vertical group of the periodic table. The replacement of groups is done on the
basis of the outer electronic configuration as well as by the ring equivalents without disturbing
the spatial arrangement of the lead molecule. In the process of improving potency of the lead
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molecule, the atoms or the groups can be replaced by the non-specific substitute which may
increase the hydrophobicity or hydrophilicity of the molecule to enhance the membrane pene-
tration or the solubility. It is necessary to understand the dissociation state of the functional
group at the physiological pH during the process of modification of the lead compound [68, 102].
The strategy of replacement leads compound group with the analogous group (]F,]OH,]
NH2 and ]CH3) and is successfully applied to design the hypoglycemic agents, inhibitory
compounds such as aminopterin, 6-mercaptopurine, 6-thioguanine, etc. The cis- and trans-
configurational similarities can also serve as the way to design better lead compound. For
example, replacement of ester functionality of the anaesthetics prolongs their action in body
which led to the group of drugs such as anticholinergic spasmolytics and anti-depressant
drugs. The pyridyl containing compound has more hydrophilicity as compared to the benzene
because of the presence of p-electron deficiency which improve the reactivity of most of the
drugs. This concept has already applied to the development of tricyclic, anti-histaminic and
neuroleptic (major tranquilizing) drugs as well as in sulfide-containing groups [69, 104].
Ring replacement of ]N< by ]HC< and its subsequent modification to >Cd have resulted
in a variety of useful drugs. This is seen in the development of psychotherapeutics
(chlorprothixene), the anti-inflammatory drug (sulindac). Several other modifications such as
reversal of group, ring opening and closure and groups with similar polar effect can lead to the
development of more potent lead compound [97].
5.2. Design from a knowledge of the catalytic mechanism
In most of the examples, the prior data on the enzyme active site are not available. The new
lead compounds are designed based on the knowledge of substrate and catalytic mechanism
followed by the reaction. The design of the molecules and their interaction with predicted
structure of enzymes can also serve as better option to design the lead compound wherein
molecular modelling plays an essential role [105–107]. The enzymes about which no data are
available, structure of substance acts as a guiding line. For example, before discovery of the
structural data of the angiotensin-converting enzyme (ACE), the inhibitors are decided based
on the knowledge of substrate and poison (snake venom) and its similarity with the carboxy-
peptidase A enzyme. The discovery that D-benzylsuccinic acid was a potent inhibitor of
carboxypeptidase A was challenged to the molecule similar to snake venom with the attach-
ment of terminal. Ala-Pro sequence leads to the development of inhibitor methyl glutamyl
proline. For the further improvements to enhance similarity between the substrates, increasing
the solubility of the compound and reduction of side effect caused the drug molecule, it
undergoes a series of changes to develop highly potent and efficient drug [78, 94, 108, 109].
Nowadays, application of computer-based molecular modelling techniques has gained the
relative importance over the conventional techniques. The highly resolved crystal structure of
the enzyme and enzyme-inhibitor complex reveals the change structural configurations, the
spatial arrangement of the inhibitor within the active site of the enzyme along with the binding
site of the enzyme and inhibitors [110–112]. On the basis of analysis of these data, the molec-
ular modelling software showed the best match for the given enzyme from the large pool for
chemical molecules in its database. These might be the completely new structures which need
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to explore for their catalytic activity. It can also suggest the best modification that can serve for
the developing potent inhibitor from the existing drugs. By using data from various sources
such as structure of inhibitors from the various crystallographic databases and crystal struc-
tures of enzymes, enzyme-substrate and enzyme-inhibitor complex from the various PBD
databases can be imported and analysed for the prediction of inhibition capacities of the
various molecules [113]. Various ab initio and drawing softwares are used for the prediction of
the structure of the inhibitors which are not present in the database. There spatial arrangement
and group and chain positions are studied and model is minimized to confirm with lowest
energy status. This is then docked inside the active site of the enzyme and positioned to have a
maximum favourable interaction and tried for the energy minimization of the system. Thus,
the finalized inhibitor then modified by various methods discussed earlier (Section 7.1) and
analysed again in the software [77, 84, 114]. The use of high-resolution NMR studies or by
homology modelling (minimum 30%) can give the relative desired protein structure. This can
be used for the further docking experiments against the library of the inhibitors using comput-
erized modelling software. The prediction of the active site on the surface of enzyme
(pharmacophore) is done by docking the multiple inhibitor molecules. Because of the basic
assumption of the rigid structure of the protein, the predicted inhibitor may differ in activity
with the dynamic enzymes molecule [115, 116]. Thus, the developed lead compounds then can
be applied in pharmaceutical, agrichemical industries and in the study of metabolic flux,
genetic engineering and molecular biology for the betterment of life.
6. Enzyme activators
Activators are the molecules that enhance the rate of reaction by multi-fold which may or may
not get utilized during the catalytic reaction progress. Depending upon their interaction with
the enzymes, they are classified into various groups. The prosthetic groups generally bind
covalently with the enzyme and act as a source of hydrogen or phosphorus group. Prosthetic
Sr. no. Reaction type Activators used
1 H-transfer reaction (vitamin-based activators) (Vitamin-based activators) NAD, NADP, FMN, FAD
2 H-transfer (non-vitamin-based activators) Lipoic acid, biopterin, coenzyme Q
3 Group transfer (vitamin based activators) CoA, CoASH, TPP, pyridoxal phosphates, tetrahydrofolic acid
(FH4), biotin, cobamide coenzyme, vitamin K, vitamins C
4 Group transfer ATP, CDP, VDP, phosphoadenosine phosphosulfate
5 Transfer (non-vitamin-based activators) (PAPs), heme-group, s-adenosylmethionine
6 Metals Mg2+—ATP utilizing enzymes
Ca2+—requires in functioning of muscle and blood clotting,
essential for formation of cAMP
Fe2+ and Fe3+—heme-nonheme containing enzymes
Cu1+ and Cu2+—electron transport systems
Zn2+—present in dehydrogenase, polymerase
Mo6+—required for functioning of xanthanine oxidase
Table 6. Different types of enzyme activator and their examples.
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group forms part of active group undergoes changes during reaction. The co-enzymes do not
bind covalently with enzymes and very essential for the activity of the enzymes. Co-enzymes
get chemically altered temporarily during the reactions which get reconverted into its original
form by the same or another enzyme. The enzymes associated co-enzyme usually catalyses
bisubstrate reactions [3, 4]. The co-factors are complex organic molecules or metal ions. Some
of the activators are listed in Table 6.
7. New developments in enzyme inhibition
In the 1970s and 1980s, the stopped flow and continuous flow experiments brought about the
major experimental advancement in enzyme kinetics field by allowing the process to reach
steady state. The complicated enzyme kinetics and intermediates formed during the process
are decoded using rapid sample mixing and high time resolution monitoring [50, 117, 118].
The application of single-molecule fluorescence imaging at room temperature for single-
molecule manipulation has been applied to study the single molecule enzyme in 1990s
[119, 120]. It gave a major breakthrough in the field of enzyme kinetics. Single-molecule
enzymology has elaborated on molecular level insights on molecular motors and nucleic acid
enzymes. In single molecule experiments, wherein the time pattern of enzymatic turnovers
was analysed, it is observed that the catalytic activity is not consistent over time. The reaction
follows parallel reaction pathway through different enzymatic conformation with different
rate constants and rate constant for the rate-limiting step might become a function of time.
This phenomenon is called dynamic disorder [120–123]. Single molecule experiments have
shown that the stochastic waiting time of an enzymatic reaction exhibits a distribution of an
exponential rise followed by an exponential decay [124, 125]. For a single molecule with slowly
interconverting conformational states with different kcat and Km, it follows that
1
〈T〉
¼
kcat½S
½S þ Km
(74)
Where 〈T〉 is the mean of the stochastic waiting time and the overbars denote the weighted
averages of kcat and Km of different conformational state.
In case of reversible reactions, Hill showed that forward and backward reaction fluxes (J+ and
J, respectively) can be related to the chemical potential difference, Δμ, between product and
the substrate:
Δμ ¼ kTln
Jþ
J
 
(75)
where k is the Boltzmann constant and T is the absolute temperature. It also serves as bridge
between the thermodynamic driving force and enzymatic kinetics.
A most commonly used fluorogenic substrate, resorufin â-D-galactopyranoside (RGP), is also
hydrolysed by the enzyme, yielding a fluorescent product, resorufin. The fluorescent burst
released during the process is used for the prediction of the single enzyme kinetics. The location,
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brightness and spectral properties of the fluorophore-labelled molecule affect the measurement
of the signal significantly. This resolution directly yields kinetic information, for example, when
measuring: (a) diffusion coefficients with respect to changes in the position of molecule (b) time-
lapse experiments to analyse the systematic change in the brightness of fluorogenic substrate
turnover with time or (c) temporal changes in molecule conformation or configuration when
observing changes in FRET between a judiciously placed donor-acceptor pair.
The microscopic validity of chemical master equation (CME) has also been tested and verified
by molecular dynamics for dilute chemical systems and using Brownian dynamics simulations
for non-dilute crowded systems. The major assumption underlying the CME is that reactions
are occurring in well-mixed environments. The characteristics of reactivity fluctuations in
individual enzyme molecules relate to the second moment of turnover time statistics which
can be defined by the randomness parameter R and time statistics. The randomness parameter
R tends to become 1, when the waiting time distribution is a single exponential decay function.
Any deviation of R from this predicted value is an indication of dynamic disorder [121]. When
this is applied for the inhibition reaction, the expressions for the waiting time distributions for
inhibition reactions became cumbersome. If more than one intermediate steps are present in
the given set of reactions, then the chemical master equations become more and more complex.
To avoid such complications, Chaudhary has used a simple analytical model based on the first
passage time distribution between successive catalytic turnover events. This probability distri-
bution function (PDF) is the moment of one monitored transition. If ϕ(t)dt is the probability of
observing the next monitored transition between time t and (t+ dt) after this time moment. The
assumption made is that there is formation of product molecules with regeneration of the free
enzyme. Such events are actually detectable in single-molecule fluorescence experiments [126].
These experiments have given the final expression for competitive inhibition can be given as
〈tcompetitive〉 ¼
½S þ ½I k3ðk1þk2Þ
k1k3
þ ðk1þk2Þ
k1
k2½S
(76)
〈tuncompetitive〉 ¼
½S þ ½I½S k3
k3
þ ðk1þk2Þ
k1
k2½S
(77)
Various researchers are applying various approaches to derive rate expression for the enzy-
matic reaction, which are under continuous evaluation to finalize more generalized and sim-
plistic equations.
8. Conclusion
Biocatalysis has evolved as a promising lead to make the chemical process more sustainable,
green and environment friendly. The main challenge in biocatalysed reactions is their indus-
trial viability and economical aspects. The advancement in genetic engineering, medium engi-
neering and immobilization technology has made them more robust to sustain the industrial
environment. To transform the lab scale process to industrial scale, the understanding of the
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enzyme kinetics, inhibition and activation becomes very essential. The fragile nature of the
enzymes makes them more sensitive towards the changes in medium and physical parameters
of the surrounding environment. The various physical parameters such as temperature, pH,
microwave and other radiations exposure, immobilization on different support affect the
activity of the enzyme and in turn the kinetics of the reaction. The kinetics of the enzymes
become more complex when the reaction becomes multi-substrate compared to single sub-
strate reactions. The different kinds of methodologies and plots are used to predict the reaction
kinetics of the multi-substrate reactions. The pattern observed during the analysis of the
obtained experimental data is used to predict the model for the reactions such as ping-pong
bi-bi or ternary complex model and mechanism of the reaction. The obtained model is then
solved using various non-linear regression softwares available for the prediction of kinetic
constants for the reaction. The inhibition or activation of the enzyme with the chemical entities
or the reactant itself further modifies the reaction kinetics and in turn model of the reaction. To
study these phenomena, a systematic research methodology needs to be followed to predict
the exact reaction kinetics. The finding then can be used to design new enzyme inhibitors,
activators which can be applied as possible drug molecules or for the prediction of the mech-
anism of the enzyme from the same family. This opens up the new area of the application such
as pharmaceutical, molecular modelling, genetics studies and industrial production of fine and
bulk chemicals. The use of the continuous and stopped flow experiments is becoming a new
field to explore and understand enzyme kinetics and its inhibition to better extend.
Abbreviations
E Enzyme
S, A Substrate
H Hydrogen
H+ Hydrogen ion
ES Enzyme-substrate form
P Product
ESH Enzyme-substrate-hydrogen form
k1 Rate constant for forward reaction to form ES
k2 Rate constant for reaction to form P
k
1 Rate constant for backward reaction to form ES
v Initial velocity
Vmax Maximum velocity
Km Michaelis Menten constant
Vmapp Apparent maximum velocity
Kmapp Apparent Michaelis Menten constant
ke1, ke2, kes1, kes2 Equilibrium constant for hydrogen binding with various enzyme form
η Effectiveness factor
Sb Amount of substrate at boundary layer
V’max Maximum velocity within matrix
vs Reaction velocity within matrix
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Ss Amount of substrate in the solution
ET Total enzyme
Ka Michaelis Menten constant for substrate A
Kia Intrinsic dissociation constant for A
Kib Intrinsic dissociation constant for B
ki Inhibition rate constant
B Second substrate
P Product 1
Q Product 2
F Stable modified form of enzyme
Kb Michaelis Menten constant for substrate B
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